Gene and Cell Therapy Scientists are pioneering a new era in medical treatments by developing innovative therapies that target the underlying causes of diseases at the genetic and cellular levels. These scientists utilize cutting-edge techniques like gene editing, viral vectors, and stem cell manipulation to repair, replace, or alter genetic material to treat or prevent diseases. Their work covers a wide range of conditions, from genetic disorders such as cystic fibrosis to cancers, autoimmune diseases, and even neurodegenerative diseases. By modifying the patient’s cells or genes, they aim to restore normal function or even eradicate diseases that were previously considered untreatable. In their work, gene and cell therapy scientists collaborate with multidisciplinary teams, including biologists, clinicians, and regulatory experts, to ensure that their therapies are both safe and effective. They focus on overcoming the challenges of delivering genes or engineered cells to the right locations in the body, managing immune responses, and scaling up production for clinical use. With the growing potential of personalized medicine, these scientists play a pivotal role in transforming laboratory findings into real-world, life-changing treatments. As the field progresses, gene and cell therapy scientists continue to push boundaries, offering new hope for patients suffering from chronic and genetic diseases, and reshaping the future of medicine.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Antibody-proteases as translational tools of the next-step generation to be applied for biopharmacy-related and precision medical practice
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Storage stability and solution binding affinity of an fc-fusion mimetic
Hanieh Khalili, University of East London, United Kingdom
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia